Marksans Pharma Ltd
Marksans Pharma Limited, together with its subsidiaries, engages in the research, manufacturing, marketing, and sale of pharmaceutical formulations in the United States, North America, Europe, the United Kingdom, Australia, New Zealand, and internationally. The company offers products in the pain management, cardiovascular, central nervous system, anti-diabetic, gastrointestinal, analgesics, upper respiratory, ear care, skincare, anticancer, anti-ulcerative, anti-allergy, antiviral, dietary, cardiac, dermatology, antihistamines, anti-fungal, anti-viral, laxatives, and cold and cough therapeutic areas. Its product portfolio includes plain, enteric-coated, and film coated tablets; soft gelatin and hard capsules; oral liquids; and ointments, as well as creams and liquids. The company provides its products to supermarkets, high street retailers, pharmacy chains, and wholesalers. Marksans Pharma Limited was incorporated in 1992 and is headquartered in Mumbai, India.
If you'd bought from year…
Same habit, different start year. Each row shows what a constant habit's worth of MRKS-NS would be worth today, had you started buying at that point in the asset's history.
| Started | $6/day$6/day coffee | $42/wk$42/week coffee |
|---|---|---|
| Year 1 (2002) — listing | $1,162,357 32.7× | $1,695,180 32.4× |
| Year 6 (2007) | $791,901 27.6× | $1,171,913 27.5× |
| Year 11 (2012) | $390,686 18.3× | $582,082 18.4× |
| Year 16 (2017) | $76,130 5.5× | $113,015 5.5× |
| Year 21 (2022) | $15,954 2.4× | $23,726 2.5× |
Repeated investment, no fees, dividends reinvested. $6/day coffee = $180 / month equivalent.
Popular scenarios with MARKSANS
For illustration only — not investment advice. Past performance is not indicative of future results.